Grifols Therapeutics Investing $351M In North Carolina Expansion

SourceBusiness Facilities
Date Published06/11/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Grifols
Parent companyGrifols
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):300
Year reshoring announced:2020
Capital investment ($):351.6
Country(ies) from which reshored:Spain
City reshored to:Clayton
State(s) reshored to:NC
If relevant, work nearshored to:-
Product(s) reshoredblood plasma
What domestic positive factors made reshoring more attractive?Proximity to customers/market, Skilled workforce availability/training
Government Incentive dollar amount:5.1
Find Reshoring Articles